101 related articles for article (PubMed ID: 30737573)
1. Combination treatment with highly bioavailable curcumin and NQO1 inhibitor exhibits potent antitumor effects on esophageal squamous cell carcinoma.
Mizumoto A; Ohashi S; Kamada M; Saito T; Nakai Y; Baba K; Hirohashi K; Mitani Y; Kikuchi O; Matsubara J; Yamada A; Takahashi T; Lee H; Okuno Y; Kanai M; Muto M
J Gastroenterol; 2019 Aug; 54(8):687-698. PubMed ID: 30737573
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of NQO1 Expression in Non-neoplastic Esophageal Squamous Epithelium for Patients With Esophageal Cancer.
Ichikawa H; Ishikawa T; Sugai M; Muneoka Y; Kano Y; Ueki H; Abe S; Moro K; Hirose Y; Miura K; Shimada Y; Sakata J; Wakai T
Anticancer Res; 2024 May; 44(5):1915-1924. PubMed ID: 38677747
[TBL] [Abstract][Full Text] [Related]
3. Romidepsin exhibits anti-esophageal squamous cell carcinoma activity through the DDIT4-mTORC1 pathway.
Xia WF; Zheng XL; Liu WY; Huang YT; Wen CJ; Zhou HH; Wu QC; Wu LX
Cancer Gene Ther; 2024 May; 31(5):778-789. PubMed ID: 38480975
[TBL] [Abstract][Full Text] [Related]
4. Targeting integrin αvβ3 with indomethacin inhibits patient-derived xenograft tumour growth and recurrence in oesophageal squamous cell carcinoma.
Liu F; Wu Q; Han W; Laster K; Hu Y; Ma F; Chen H; Tian X; Qiao Y; Liu H; Kim DJ; Dong Z; Liu K
Clin Transl Med; 2021 Oct; 11(10):e548. PubMed ID: 34709754
[TBL] [Abstract][Full Text] [Related]
5. Development of targeted therapy of NRF2
Paiboonrungruang C; Simpson E; Xiong Z; Huang C; Li J; Li Y; Chen X
Cell Signal; 2021 Oct; 86():110105. PubMed ID: 34358647
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Isoplumbagin as a Novel NQO1 Substrate and Anti-Cancer Quinone.
Tsao YC; Chang YJ; Wang CH; Chen L
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575541
[TBL] [Abstract][Full Text] [Related]
7. Eosinophils Exert Antitumorigenic Effects in the Development of Esophageal Squamous Cell Carcinoma.
Jacobse J; Aziz Z; Sun L; Chaparro J; Pilat JM; Kwag A; Buendia M; Wimbiscus M; Nasu M; Saito T; Mine S; Orita H; Revetta F; Short SP; Kay Washington M; Hiremath G; Gibson MK; Coburn LA; Koyama T; Goettel JA; Williams CS; Choksi YA
Cell Mol Gastroenterol Hepatol; 2023; 16(6):961-983. PubMed ID: 37574015
[
